Key Takeaways
- QS shares finished Friday at $6.08, gaining 9.8% for the day and 16.5% for the week
- The advance occurred without company-specific news; broader battery sector momentum lifted multiple names
- Dimensional Fund Advisors expanded its QS position by 134.6% during Q1, acquiring 3.29 million additional shares
- Company insiders divested 687,540 shares totaling roughly $5.6 million in the last three months
- Wall Street consensus leans toward “Reduce” with a mean price objective of $6.66, representing just 9.5% upside from current levels
QuantumScape (QS) finished Friday’s session, August 7, at $6.08 per share, marking a 9.8% daily advance. This extended the stock’s weekly performance to a 16.5% increase from its July 31 settlement price.
The surge came without any fresh corporate disclosure. A review of QuantumScape’s investor relations portal revealed July 22 as the most recent press release date.
QS wasn’t alone in its climb. Fellow battery technology companies also posted gains: SES AI jumped 10.6%, Solid Power advanced 6.6%, and Amprius Technologies added 5.9% during the same trading day. This sector-wide strength suggests improved risk appetite for battery innovators rather than company-specific developments.
The stock continues trading in the lower half of its 52-week price band, which spans from $4.77 to $19.07. The 50-day moving average currently rests at $6.95.
Large Funds Accumulate Shares
Dimensional Fund Advisors substantially expanded its QuantumScape position during the first quarter, adding 3.29 million shares—a 134.6% increase. This brought the firm’s total holding to 5.74 million shares, valued at approximately $36.6 million based on regulatory filing data.
Additional institutional buyers emerged across recent quarters. Morgan Stanley grew its stake by 333.5% in Q4. UBS Asset Management expanded holdings by 456.5% in Q1. Vanguard increased its position by 11.8% in Q4, now controlling more than 40.9 million shares. Institutional ownership now represents 29.87% of outstanding stock.
While large funds accumulated, corporate insiders reduced their holdings. Director Jeffrey Straubel disposed of 27,106 shares in May at $7.85 each. CTO Timothy Holme sold 150,320 shares in June at $9.30 per share. Collectively, insiders offloaded 687,540 shares valued at roughly $5.6 million during the trailing 90-day period. Insider ownership now stands at 3.93%.
Market Capitalization Exceeds Financial Foundation
QuantumScape’s market capitalization stood at $3.75 billion following Friday’s close. The company disclosed Q2 liquidity of $859 million. This creates a valuation multiple of approximately 4.4 times cash resources, representing a $2.89 billion premium unsupported by current commercial operations.
The enterprise remains in its development phase without generating GAAP-recognized revenue. Second-quarter customer billings totaled $10.8 million but weren’t recorded as revenue per accounting standards.
Expense management showed progress. Operating expenditures decreased 14.1% year-over-year to $106.1 million. Net losses contracted 14.4% to $98.2 million. Operating cash consumption improved 8.2% to $56.7 million.
Management maintained full-year adjusted EBITDA loss guidance between $250 million and $275 million. Capital expenditure guidance was reduced to a range of $27 million to $37 million.
Honda formalized a multi-year research partnership with QuantumScape in June. Honda R&D executive Atsushi Ogawa stated that “QS technology demonstrated compelling and unique advantages during our evaluation.” However, research collaborations differ from binding production commitments.
The Volkswagen PowerCo commercialization arrangement underwent revision in July 2026. Maximum program compensation was reduced from $130.7 million to $75.4 million—a $55.3 million decrease. QuantumScape collected $10.4 million in Q2 under the modified agreement terms.
Wall Street maintains a reserved outlook. Among nine analysts monitored by S&P Global, seven assign Hold ratings while two recommend Strong Sell. The consensus price target sits at $6.66, with projections spanning $2.50 to $10.00. TD Cowen lowered its target from $8 to $6 on July 24.



